VenCap International

About VenCap International

VenCap International plc is one of the United Kingdom longest-established dedicated venture capital fund-of-funds, founded in 1987 by Michael Ashall. The firm is headquartered in Oxford, United Kingdom and is authorised and regulated by the UK Financial Conduct Authority. Across its nearly 40-year history VenCap has committed in excess of USD 3.0 billion of capital across approximately 500 underlying venture capital funds in the United States, Europe, China and India, and has raised cumulatively around USD 2.4 billion across its dedicated funds-of-funds and segregated separate-account mandates. As of December 2024, assets under management are in the order of €2.0 billion equivalent. VenCap operates as an independent partnership: it is not owned by, nor affiliated with, any bank, insurer or larger asset manager, preserving conflict-free manager-selection. Successive VenCap fund-of-funds vehicles have been raised on roughly four-year cycles. The firm is a signatory to the UN Principles for Responsible Investment. VenCap has built a multi-decade dataset on venture-fund performance that informs its concentrated manager-selection thesis.

Investment thesis

VenCap thesis is rooted in the empirical power law observation that the great majority of venture returns are generated by a small number of outlier companies, and that a small subset of general partners consistently back those outliers. The firm constructs concentrated portfolios of approximately 10 to 15 underlying VC managers per fund vintage, deliberately rejecting broad diversification in favour of repeated high-conviction commitments to top-tier franchises in Silicon Valley, the US East Coast, Europe, China and India. Strategies covered span Seed, Early-stage and Multi-stage venture, with selective Growth exposure obtained via the same anchor managers. Ticket sizes per underlying fund commitment typically range from USD 10 million to USD 50 million, with larger separate-account commitments deployed for institutional clients. The limited partner base comprises leading global institutional investors, sovereign wealth funds, pension plans, endowments, foundations, insurance companies and family offices across Europe, North America, the Middle East and Asia. Value creation rests on decades of proprietary GP-performance data, long-standing GP relationships that secure access to over-subscribed funds, and selective co-investment access alongside underlying managers.

Recent activity

Recent activity (as a fund-of-funds, the firm investments are commitments to underlying VC managers rather than direct deals) spans AI and generative AI in software (2024, via underlying managers backing leading foundation-model labs), healthcare AI in software and healthcare (2024 to 2025, via underlying exposure to leading clinical-AI platforms), defence tech in industrials (2024) and fintech in financial services (2024). Recent underlying liquidity events flowing back through GP partners include software IPOs and exits across the cumulative VenCap portfolio, with landmark realisations historically spanning CrowdStrike in software (IPO Nasdaq), Snowflake in software (IPO NYSE), Coinbase in financial services (IPO direct listing) and UiPath in software (IPO NYSE). Detailed buyer names and multiple data available on Pro at €29/month.